Alzheimer’s Disease is a neurodegenerative disease associated with progressive memory loss, loss of cognitive function and loss of autonomy. It affects 44 million people globally and is expected to double by 2030. It has variable onset, rates of progression and disease severity and is multi-factorial, has many genetic factors and is estimated to have an inheritance rate of 60-80%.
Currently this disease has no medical intervention that has a greater impact than a placebo.
The early signs of AD include: Memory loss that disrupts daily life, Challenges in planning or solving problems, Difficulty completing familiar tasks at home, at work, or at leisure, Confusion with time or place, Trouble understanding visual images and spatial relationships, New problems with words in speaking or writing, Misplacing things and losing the ability to retrace steps, Decreased or poor judgment, Withdrawal from work or social activities and Changes in mood and personality.
Prevention is the best medicine!
The MemoryDNA Panel is the most advanced diagnostics panel analyzing your genomics to asses the potential risk factors associated with cognitive decline and Alzheimer’s Disease. Paired with metabolomics testing, OmicsDx will synthesize your genomic risk factors and offer nutritional suggestions based on your testing results. Nutrition counseling is strongly recommended and can be scheduled with a certified nutrition specialist at the Nutritional Genomics Institute.
Required Testing: Nutreval, Lipid Panel, CBC, CMP, Insulin, Vitamin D